Measuring Impact of Corporate Responsbility Programmes

1

Measuring Impact of Corporate Responsibility Programmes January 22, 2014 Dominic Kemps Director, Positive Action for Children Fund

ViiV Healthcare

• HIV Specialist Pharmaceutical company

• Joint venture between GSK & Pfizer launched in 2009, joined by Shionogi in 2013

• ViiV exists in 15 markets globally and is represented by GSK elsewhere

2

What is Corporate Responsibility?

3

So many different things??!!??

Why Corporate Responsibility?

4

Core = Heart of Business

Internally Driven

Department to Keep Critics at bay

Externally Aligned . ViiV

• Over 300 partnerships • £10-11M PY

. Set a strategy and seek partners who fit

. Respond to cold requests

Unplanned/Reactive

Note: each activity’s placement will vary by organisation

How do you measure? Is it Rankings?

5

Source: http://www.fcaaids.org/AIDSFunding/ResourceTrackingReport/tabid/305/Default.aspx

How do you measure? Is it Press Clippings and Partners?

6

ViiV Healthcare Collaborates with Clinton Health Access Initiative (CHAI) & Mylan Pharmaceuticals on First-of-its-Kind Agreement to Provide a Paediatric Dispersible Fixed Dose Combination for Treatment of HIV Establishes Five New Partnerships to Promote Paediatric HIV Research, Treatment and Care Initiatives

“Passion, unmet

needs drives

ViiV/Mylan/CHAI

pediatric HIV effort”

How do you measure? Is it licences/in-kind donations?

7

In 2012, 1.1 billion tablets (3TC, ZDV/3TC) were manufactured by ViiV HC and ViiV HC licensee's (approx. 12 months supply for 1,500,000 patients)

How do you measure? Endless measures

• Results can be measured in many ways

– eg. Carbon impact, waste disposal, volunteering, funding, employee relations, local community goodwill, press, supply chain

• CR can build trust, demonstrate contribution beyond profit, employment, share price etc....

8

ViiV CR – 3rd Pillar of the Business 1st Pillar R&D Science; 2nd Pillar Commercial Business

Access: Scale up the numbers of people receiving ARV treatment through:

1. Non-for-profit pricing 2. Voluntary Licences, Royalty Free 3. Preferential Pricing

Care: Access to Medicines is underpinned by:

1. Positive Action 2. £50 million Positive Action for Children Fund 3. £10 million R&D project to deliver new paediatric FDC and

formulations

Summary All ViiV Healthcare Funded Programmes Globally 2012-13*

Only Funding (PA and/or PACF and/or ViiV HQ) Only Licences (VLs and/or MPP) Funding + Licences ViiV Country Funding Only ViiV Country Funding and ViiV HQ Funding

*ViiV HQ and LOCs, but not Alliance Markets

PACF Global Alignment

11

• Focus on community interventions to end vertical transmission from mother to child

• 150 partnerships, 85 receiving Technical Assistance

• PACF Programmes fully aligned to 4 prongs of WHO PMTCT Strategy (http://www.who.int/hiv/pub/mtct/strategic_vision.pdf) and Global Plan (http://www.who.int/hiv/pub/mtct/strategic_vision.pdf)

Positive Action for Children Fund

Since 2010, the PACF has committed nearly £20million to 152 Grantees tackling vertical transmission from mother to child in 30 countries

Americas 2 partners

CIS 3 partners

Asia 5 Partners

Africa 140 Partners

Alignment with Global Plan Priority Countries

PACF Programmes and country progress towards ending vertical transmission

13

Rapid Decline Moderate Decline Slow or No Decline

Ethiopia L (3),S (4) Botswana Angola

Ghana Burundi L (1) Chad

Kenya L(5), S (4) Cameroon L (2), S (4) DRC L(3), S (8)

Namibia Ivory Coast L (1), S (1) Mozambique L (2)

South Africa S (4) Lesotho L(1), S (1) Nigeria L (1), S (6)

Swaziland L (1) Malawi S (7) Tanzania S (2)

Zambia L(1), S (9) Uganda L (6), S (9) India L (3), S (1)

Zimbabwe S (12)

L = Large Grantee S = Small Grantee (x) = Number of grantees

Note: Valid as of July 2013

Selected PACF Results to date

• 1,184,259 reached through all activities

• 168,668 referrals into health systems

• 110,613 women tested

• 11,220 testing positive

• 16,907 births in facility

• 124,782 outreach workers trained

14

Source: PACF Grantee Reports 2010-12. Valid through July 2013

• Thank you

• Questions

• [email protected]

15